ThermoGenesis Holdings, Inc.
General ticker "THMO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.0K (TTM average)
ThermoGenesis Holdings, Inc. does not follow the US Stock Market performance with the rate: -19.2%.
Estimated limits based on current volatility of -0.1%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 25 (-39.0%) as of 2023
- US accounted for 63.8% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Manufacturing risks, Labor/talent shortage/retention, Cybersecurity threats, Regulatory and compliance, Pandemic risks
- Current price 100.0% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.39$, 1.26$]
- 2024-12-30 to 2025-12-30 estimated range: [0.29$, 0.94$]
Financial Metrics affecting the THMO estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -262.91 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term THMO quotes
Long-term THMO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $9.29MM | $10.48MM | $9.45MM |
| Operating Expenses | $16.52MM | $16.68MM | $18.05MM |
| Operating Income | $-7.23MM | $-6.19MM | $-8.61MM |
| Non-Operating Income | $-4.65MM | $-5.62MM | $-10.31MM |
| Interest Expense | $6.10MM | $5.62MM | $10.03MM |
| R&D Expense | $2.21MM | $1.66MM | $1.28MM |
| Income(Loss) | $-11.88MM | $-11.81MM | $-18.92MM |
| Profit(Loss)* | $-11.38MM | $-11.27MM | $-17.98MM |
| Stockholders Equity | $3.83MM | $4.30MM | $-1.67MM |
| Inventory | $5.37MM | $3.33MM | $1.41MM |
| Assets | $20.65MM | $19.39MM | $11.23MM |
| Operating Cash Flow | $-6.62MM | $-7.28MM | $-3.72MM |
| Capital expenditure | $0.09MM | $0.40MM | $1.73MM |
| Investing Cash Flow | $-0.09MM | $-0.40MM | $-1.73MM |
| Financing Cash Flow | $6.83MM | $4.59MM | $3.28MM |
| Earnings Per Share** | $-43.41 | $-20.45 | $-7.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.